Positron emission tomography in assessing response to neoadjuvant chemotherapy for non-small-cell lung cancer

被引：0
|
作者：
O'Donnell, GJ [1 ]
机构：
[1] Victorian Imaging Grp, Clayton S, Vic 3169, Australia
来源：
MEDICAL JOURNAL OF AUSTRALIA | 1999年 / 170卷 / 05期
关键词：
D O I：
10.5694/j.1326-5377.1999.tb140333.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：236 / 237
页数：2
相关论文
共 50 条
  • [41] Mediastinal lymph node staging of non-small-cell lung cancer: A prospective comparison of computed tomography and positron emission tomography
    Scott, WJ
    Gobar, LS
    Terry, JD
    Dewan, NA
    Sunderland, JJ
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1996, 111 (03): : 642 - 648
  • [42] Molecular predictors of chemotherapy response in non-small-cell lung cancer
    Gray, Jhanelle
    Simon, George
    Bepler, Gerold
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (04) : 545 - 549
  • [43] Early Response to Chemotherapy in Patients With Non-Small-Cell Lung Cancer Assessed by [18F]-Fluoro-Deoxy-D-Glucose Positron Emission Tomography and Computed Tomography
    Novello, Silvia
    Vavala, Tiziana
    Levra, Matteo Giaj
    Solitro, Federica
    Pelosi, Ettore
    Veltri, Andrea
    Scagliotti, Giorgio V.
    CLINICAL LUNG CANCER, 2013, 14 (03) : 230 - 237
  • [44] Neoadjuvant or adjuvant chemotherapy for non-small-cell lung cancer: Does the timing matter?
    Zhang, Yang
    Chen, Haiquan
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2019, 157 (02): : 756 - 757
  • [45] Neoadjuvant chemotherapy with gemcitabine and vinorelbine in resectable non-small-cell lung cancer (NSCLC)
    Sommers, E
    Ramnath, N
    Robinson, L
    Nwogu, C
    Tan, D
    Sharma, A
    Cantor, A
    Chiappori, A
    Williams, C
    Bepler, G
    LUNG CANCER, 2005, 49 : S96 - S97
  • [46] Pathologic Response to Neoadjuvant PD-1 Inhibitors and Chemotherapy in Squamous Non-Small-Cell Lung Cancer
    Shi, L.
    Liu, Z.
    Meng, Q.
    Tong, L.
    Li, H.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S979 - S979
  • [47] Neoadjuvant chemotherapy in non small cell lung cancer
    Besse, Benjamin
    Vignot, Stephane
    Le Chevalier, Thierrv
    BULLETIN DU CANCER, 2006, 93 (11) : 1087 - 1092
  • [48] Variations in positron emission tomography-computed tomography findings for patients receiving neoadjuvant and non-neoadjuvant therapy for non-small cell lung cancer
    Park, Jae Kil
    Kim, Jae Jun
    Moon, Seok Whan
    JOURNAL OF THORACIC DISEASE, 2017, 9 (02) : 344 - 354
  • [49] Computed Tomography RECIST Assessment of Histopathologic Response and Prediction of Survival in Patients with Resectable Non-Small-Cell Lung Cancer after Neoadjuvant Chemotherapy
    William, William N., Jr.
    Pataer, Apar
    Kalhor, Neda
    Correa, Arlene M.
    Rice, David C.
    Wistuba, Ignacio I.
    Heymach, John
    Lee, J. Jack
    Kim, Edward S.
    Munden, Reginald
    Gold, Kathryn A.
    Papadimitrakopoulou, Vassiliki
    Swisher, Stephen G.
    Erasmus, Jeremy J.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (02) : 222 - 228
  • [50] [18F] fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer
    Sasaki, R
    Komaki, R
    Macapinlac, H
    Erasmus, J
    Allen, P
    Forster, K
    Putnam, JB
    Herbst, RS
    Moran, CA
    Podoloff, DA
    Roth, JA
    Cox, JD
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (06) : 1136 - 1143
12345